Product Description
Capnography (Phillips MP20 monitor) for Hypoxia (Sourced from: https://clinicaltrials.gov/ct2/show/NCT01507623)
Mechanisms of Action: N/A
Novel Mechanism: No
Modality: N/A
Route of Administration: Nasal
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: University Hospital, Gentoftepenhagen
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| NAPS | N/A |
Completed |
Hypoxia |
2011-02-01 |